Link to New York Times Article:
http://www.nytimes.com/2008/11/14/health/14hiv.html
Last November it was reported from doctors in Berlin that an AIDS patient had been cured by transplanted blood stem cells. While this is a very exciting development on the war against AIDS, it is noted that his procedure would be "unthinkable for millions infected in Africa and impractical even for insured patients in top research hospitals," due to the high risk of the stem cell transplant.
The issue comes up in not only whether we should be using stem cell research at all, but in the ethical aspect of whether this procedure is fair to use if there's no hope of being available and/or benefiting the public who also have this rare genetic mutation? There are millions of infected people all over the world, especially in Africa, who may also have this mutation that could benefit from this, but we will never know because there isn't enough funding to research. How can we decide to save some, while let other suffer though?
Personally, while I find it quite unfortunate that this procedure first, cannot be offered to everyone (whether it's due to not having this rare genetic mutation, or do to a lack of resources), I believe it would be unethical not to proceed with further researching this AIDS cure. WIth further research we may find a way to progress to have similar treatment that could save millions of lives. The benefits seem to outweigh the bad, and thus further encourage science to investigate this procedure for a possible cure for everyone.

No comments:
Post a Comment